Iron Home > Curriculum > Curriculum 5 > Iron Overload in Rare Anaemias
Iron Overload in Rare Anaemias
Diamond-Blackfan anaemia, aplastic anaemia, and pyruvate kinase deficiency are examples of rare anaemias that can result in iron overload and related organ damage. In this webcast, Dr. John B. Porter describes the various rare anaemias, the mechanisms by which iron overload can develop in affected individuals, and data regarding iron overload consequences. He will also discuss the response of iron markers and haematologic parameters to chelation therapy in patients with rare anaemias.
Target AudienceThis activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
- Assess the clinical presentation and consequences of iron overload in patients with rare anaemias in order to identify patients who would benefit from chelation therapy.
- Evaluate the response of iron markers and haematologic parameters to chelation therapy in patients with aplastic anaemia and other rare anaemias.
||John B. Porter, MA, MD, FRCP
Professor, Department of Haematology
University College London
London, United Kingdom
|John B. Porter, MA, MD, FRCP
has received grant/research support from and is on the speakers bureau of Novartis Pharmaceuticals Corporation; and is a consultant for Genzyme Corporation, Resonance Health Ltd, and Novartis Pharmaceuticals Corporation.
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
1 avenue Claude Vellefaux.
75475 Paris Cedex 10, France
All Rights Reserved
Copyright ESH 2020